Thromboembolic events in peripartum cardiomyopathy: Results from the ESC EORP PPCM registry
- PMID: 37092321
- DOI: 10.1002/ejhf.2871
Thromboembolic events in peripartum cardiomyopathy: Results from the ESC EORP PPCM registry
Comment in
-
Thromboembolic events in peripartum cardiomyopathy: Current dilemmas and future perspectives.Eur J Heart Fail. 2023 Aug;25(8):1467-1469. doi: 10.1002/ejhf.2937. Epub 2023 Jun 21. Eur J Heart Fail. 2023. PMID: 37323088 No abstract available.
References
-
- Hoes MF, Arany Z, Bauersachs J, Hilfiker-Kleiner D, Petrie MC, Sliwa K, et al. Pathophysiology and risk factors of peripartum cardiomyopathy. Nat Rev Cardiol. 2022;19:555-65.
-
- Sliwa K, van der Meer P, Petrie MC, Frogoudaki A, Johnson MR, Hilfiker-Kleiner D, et al. Risk stratification and management of women with cardiomyopathy/heart failure planning pregnancy or presenting during/after pregnancy: a position statement from the Heart Failure Association of the European Society of Cardiology Study Group on Peripartum Cardiomyopathy. Eur J Heart Fail. 2021;23:527-40.
-
- Kolte D, Khera S, Aronow WS, Palaniswamy C, Mujib M, Ahn C, et al. Temporal trends in incidence and outcomes of peripartum cardiomyopathy in the United States: a nationwide population-based study. J Am Heart Assoc. 2014;3:e001056.
-
- Sliwa K, Petrie MC, van der Meer P, Mebazaa A, Hilfiker-Kleiner D, Jackson AM, et al. Clinical presentation, management, and 6-month outcomes in women with peripartum cardiomyopathy: an ESC EORP registry. Eur Heart J. 2020;41:3787-97.
-
- Greer IA. Pregnancy complicated by venous thrombosis. N Engl J Med. 2015;373:540-7.